BetterLife Pharma Inc.

BETRF OTC SEC CIK 1464165
Follow BetterLife Pharma Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2018 USD · US GAAP
Net income −$121.2K +98.1% vs prior year
EPS, diluted $0.00 +100% vs prior year
Operating cash flow −$395.6K −10.1% vs prior year
Operating income −$1M +82.6% vs prior year
Net income by fiscal year
$341.4K
−$1.1M
−$10.3M
−$6.3M
−$121.2K
FY13 FY15 FY16 FY17 FY18

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income12 fiscal years
−$15M−$10M−$5M$0$5MFY08FY10FY12FY14FY16FY18
Show the numbers
YearNet income
FY18−$121.2K
FY17−$6.3M
FY16−$10.3M
FY15−$1.1M
FY14-
FY13$341.4K
FY12$1.4M
FY11−$3M
FY10−$120.1K
FY09−$653.8K
FY08-
FY07-